Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hilgard

Showing results (111-120 of 135) with videos related to

Pageof 14
Sort By:
Biochemical Pharmacology|June 29, 1995
Induction of the c-myc but not the cH-ras promoter by platinum compoundsA G Eliopoulos, D J Kerr, H R Maurer, et al.
Anticancer Research|May 1, 1991
Antiinvasive activity of hexadecylphosphocholine in vitroD C Schallier, E A Bruyneel, G A Storme, et al.
Arzneimittel-Forschung|March 1, 1995
Synthesis and antitumor activity of two ifosfamide analogs with a five-membered ringB Kutscher, U Niemeyer, J Engel, et al.
Biomedical Mass Spectrometry|September 1, 1985
Identification and quantification of metabolite conjugates of activated cyclophosphamide and ifosfamide with mesna in urine by ion-pair extraction and fast atom bombardment mass spectrometryI Manz, I Dietrich, M Przybylski, et al.
Lancet (London, England)|October 6, 1979
Prostacyclin deficiency in thrombotic thrombocytopenic purpuraC N Hensby, P J Lewis, P Hilgard, et al.
British Journal of Anaesthesia|November 1, 1975
Thrombin-induced disseminated intravascular coagulation. III:Modification by dextran infusionJ Jastzebski, M K Sykes, P Hilgard, et al.
Zeitschrift Fur Gastroenterologie|January 22, 2009
[Selective internal radiotherapy (radioembolization) and radiation therapy for HCC--current status and perspectives]P Hilgard, S Müller, M Hamami, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 1996
Pharmacological studies with cetrorelix (SB-75), a potent antagonist of luteinising hormone-releasing hormoneT Reissmann, T Klenner, W Deger, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1992
Treatment of experimental DMBA induced mammary carcinoma with Cetrorelix (SB-75): a potent antagonist of luteinizing hormone-releasing hormoneT Reissmann, P Hilgard, J H Harleman, et al.
European Journal of Cancer & Clinical Oncology|September 1, 1988
Characterization of the antitumor activity of hexadecylphosphocholine (D 18506)P Hilgard, J Stekar, R Voegeli, et al.
Pageof 14

Showing results (111-120 of 135) with videos related to

Sort By:
Pageof 14
Biochemical Pharmacology|June 29, 1995
Induction of the c-myc but not the cH-ras promoter by platinum compoundsA G Eliopoulos, D J Kerr, H R Maurer, et al.
Anticancer Research|May 1, 1991
Antiinvasive activity of hexadecylphosphocholine in vitroD C Schallier, E A Bruyneel, G A Storme, et al.
Arzneimittel-Forschung|March 1, 1995
Synthesis and antitumor activity of two ifosfamide analogs with a five-membered ringB Kutscher, U Niemeyer, J Engel, et al.
Biomedical Mass Spectrometry|September 1, 1985
Identification and quantification of metabolite conjugates of activated cyclophosphamide and ifosfamide with mesna in urine by ion-pair extraction and fast atom bombardment mass spectrometryI Manz, I Dietrich, M Przybylski, et al.
Lancet (London, England)|October 6, 1979
Prostacyclin deficiency in thrombotic thrombocytopenic purpuraC N Hensby, P J Lewis, P Hilgard, et al.
British Journal of Anaesthesia|November 1, 1975
Thrombin-induced disseminated intravascular coagulation. III:Modification by dextran infusionJ Jastzebski, M K Sykes, P Hilgard, et al.
Zeitschrift Fur Gastroenterologie|January 22, 2009
[Selective internal radiotherapy (radioembolization) and radiation therapy for HCC--current status and perspectives]P Hilgard, S Müller, M Hamami, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 1996
Pharmacological studies with cetrorelix (SB-75), a potent antagonist of luteinising hormone-releasing hormoneT Reissmann, T Klenner, W Deger, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1992
Treatment of experimental DMBA induced mammary carcinoma with Cetrorelix (SB-75): a potent antagonist of luteinizing hormone-releasing hormoneT Reissmann, P Hilgard, J H Harleman, et al.
European Journal of Cancer & Clinical Oncology|September 1, 1988
Characterization of the antitumor activity of hexadecylphosphocholine (D 18506)P Hilgard, J Stekar, R Voegeli, et al.
Pageof 14